An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes (MOSAIc)

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1080221979

Enrollment

150

Registered

2012-12-14

Start date

2012-12-14

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2

Interventions

investigational material(s) Generic name etc : Insulin INN of investigational material : Therapeutic category code : 249 Other hormone preparations (including antihormone preparations) Dosage and Adm

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: -Have been diagnosed with type 2 diabetes -Have presented within the normal course of care -Have been on their initial insulin therapy for 3months (with or without any combination of approved noninsulin anti-diabetic medications) -Are not simultaneously participating in a study that includes an investigational drug or procedure at entry into the study -Have been fully informed and have given written consent for the use of their data -Have a sufficient understanding of the primary language of the country such that they will be able to complete the questionnaires -Have not initiated basal bolus therapy (Three mealtime and bedtime insulin injections)

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Risk factors associated with progression from initial insulin therapy	—

Secondary

Measure	Time frame
Number of participants with failure to achieve Glycosylated Hemoglobin (HbA1c) less than 1.2 times upper limit of normal. Number of hypoglycemic episodes. Number of participants adhering to prescribed insulin therapy.	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026